News | December 13, 2007

FDA Advisory Panel Finds Hologic’s Permanent Contraception Approvable

December 14, 2007 – Hologic Inc. announced today the FDA Obstetrics and Gynecology Devices Advisory Panel recommended that the pre-market application for Adiana Permanent Contraception for female sterilization is approvable, contingent upon several conditions, including long-term follow up of current pivotal trial patients, a new post approval study of new patients and physicians, and more specific labeling recommendations.

The FDA is not required to accept, but traditionally follows the recommendations of its advisory panels.

Bilateral tubal ligation, commonly referred to as “getting your tubes tied”—is the most common form of contraception used throughout the world. Approximately 700,000 tubal ligation surgical procedures are performed annually in the U.S. alone. The surgery is typically performed in a hospital operating room under general anesthesia and requires the physician to make one or two incisions in the abdomen. This usually requires approximately four to five days of recuperation.

In contrast, Adiana is a minimally invasive, nonincisional alternative. This procedure uses hysteroscopy, generally requires only local anesthesia, and can be performed in a physician’s office. Patients are typically able to return to work or resume their everyday activities within a day.

The pivotal clinical trial to demonstrate the safety and effectiveness of Adiana in providing permanent contraception was conducted in the U.S., Australia and Mexico. As part of the clinical trial, 645 women between the ages of 21 and 45 had treatment attempted with Adiana. The procedure showed a strong safety profile, with very high device placement success, patient tolerance, comfort and satisfaction. A pregnancy prevention efficacy rate of 98.9 percent after 12 months of reliance on Adiana was demonstrated, successfully meeting the trial’s primary endpoint. This efficacy result also compares favorably with the results of the CREST Study (U.S. Collaborative Review of Sterilization), which examined the long-term failure of tubal ligation for sterilization.

For more information: www.hologic.com

Related Content

News | February 11, 2010
February 11, 2010 – former president Bill Clinton received two coronary stents today after being admitted to the...
Technology | September 09, 2008
Abbott Vascular will showcase its XIENCE V Everolimus Eluting Coronary Stent System, indicated for the treatment of c
News | April 08, 2008
April 8, 2008 – Students at Ivy Tech Community College in Bloomington, IN, will be the first in the nation to be offe
News | April 07, 2008
April 8, 2008 - The government on Monday said it would raise payments next year to insurers that provide healthcare c
News | March 16, 2008
March 17, 2008 - The American public believes doctors and physicians would do a good job running hospitals in their c
News | October 28, 2007
October 29, 2007 - Lake Hospital System today said it has invested in VaproSure Room Sterilizer technology, giving th

Dr. Gerety, a radiologist at St. Mary's Hospital, is sitting at the AMICAS PACS workstation.

Case Study | October 18, 2007
“St.

A traditional palliative treatment with two treatment fields aimed from the

Case Study | October 18, 2007
Each year, some 4,000 patients receive treatment at The Ottawa Hospital Cancer Center (TOHCC).

Dedicated Bustleton staff enjoy the benefits of the PACS and other advanced healthcare IT technology.

Case Study | October 18, 2007
Maybe it’s his personal resolve or dedication to a family business.
Overlay Init